filgrastim
pharmaceutical drug
Press Enter · cited answer in seconds
0 sources
Summary
filgrastim is a type of chemical entity[1]. filgrastim ranks in the top 5% of type of chemical entity entities by monthly Wikipedia readership (1,109 views/month).[2]
Key Facts
- Subclass of: granulocyte colony-stimulating factor[3], granulocyte-macrophage colony-stimulating factor[4], recombinant protein[5]
- Has use: medication[6]
- Commons category: Filgrastim[7]
- Has characteristic: biopharmaceutical[8]
- Different from: Colony stimulating factor 2[9]
- Medical condition treated: neutropenia[10], myelodysplastic syndrome[11], acute myeloid leukemia[12], diffuse large B-cell lymphoma[13], agranulocytosis[14], B-cell lymphoma[15]
- World Health Organisation international non-proprietary name: filgrastim[16]
- Subject has role: hematologic agent[17], essential medicine[18], developmental toxicant[19]
- Active ingredient in: Accofil[20], Biograstim[21], Filgrastim Hexal[22], Filgrastim Ratiopharm[23], Grastofil[24], Nivestim[25], Ratiograstim[26], Tevagrastim[27], Zarzio[28]
- Defined daily dose: 0.35 milligram[29]
Why It Matters
filgrastim has Wikipedia articles in 19 language editions, a strong signal of global cultural recognition.[30] filgrastim is known by 17 alternative names across languages and contexts.[31]